Compare Novartis with AUSOM ENTERPRISE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs AUSOM ENTERPRISE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS AUSOM ENTERPRISE NOVARTIS/
AUSOM ENTERPRISE
 
P/E (TTM) x 85.8 4.9 1,740.5% View Chart
P/BV x 2.7 0.7 366.3% View Chart
Dividend Yield % 1.3 0.8 154.1%  

Financials

 NOVARTIS   AUSOM ENTERPRISE
EQUITY SHARE DATA
    NOVARTIS
Mar-21
AUSOM ENTERPRISE
Mar-21
NOVARTIS/
AUSOM ENTERPRISE
5-Yr Chart
Click to enlarge
High Rs77084 920.5%   
Low Rs50124 2,131.9%   
Sales per share (Unadj.) Rs154.5342.1 45.1%  
Earnings per share (Unadj.) Rs8.516.1 52.4%  
Cash flow per share (Unadj.) Rs13.416.2 82.9%  
Dividends per share (Unadj.) Rs10.000.50 2,000.0%  
Avg Dividend yield %1.60.9 168.6%  
Book value per share (Unadj.) Rs289.281.6 354.3%  
Shares outstanding (eoy) m24.6913.62 181.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10.2 2,626.8%   
Avg P/E ratio x75.13.3 2,261.2%  
P/CF ratio (eoy) x47.53.3 1,430.4%  
Price / Book Value ratio x2.20.7 334.7%  
Dividend payout %118.13.1 3,812.5%   
Avg Mkt Cap Rs m15,691730 2,149.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0852 70,006.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8144,660 81.8%  
Other income Rs m332101 327.5%   
Total revenues Rs m4,1464,761 87.1%   
Gross profit Rs m267221 120.6%  
Depreciation Rs m1220 93,538.5%   
Interest Rs m7754 143.3%   
Profit before tax Rs m400269 148.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m19149 390.7%   
Profit after tax Rs m209220 95.1%  
Gross profit margin %7.04.7 147.4%  
Effective tax rate %47.818.2 262.3%   
Net profit margin %5.54.7 116.2%  
BALANCE SHEET DATA
Current assets Rs m9,2242,492 370.2%   
Current liabilities Rs m3,5731,940 184.1%   
Net working cap to sales %148.211.8 1,252.5%  
Current ratio x2.61.3 201.1%  
Inventory Days Days17639 453.2%  
Debtors Days Days3793,438,402 0.0%  
Net fixed assets Rs m2,480563 440.8%   
Share capital Rs m123136 90.6%   
"Free" reserves Rs m7,018976 719.3%   
Net worth Rs m7,1411,112 642.3%   
Long term debt Rs m00-   
Total assets Rs m11,7033,054 383.2%  
Interest coverage x6.26.0 103.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.31.5 21.4%   
Return on assets %2.49.0 27.3%  
Return on equity %2.919.8 14.8%  
Return on capital %6.729.0 23.0%  
Exports to sales %9.380.5 11.5%   
Imports to sales %078.5 0.0%   
Exports (fob) Rs m3543,753 9.4%   
Imports (cif) Rs mNA3,659 0.0%   
Fx inflow Rs m3543,753 9.4%   
Fx outflow Rs m9743,659 26.6%   
Net fx Rs m-62194 -663.1%   
CASH FLOW
From Operations Rs m-692834 -83.0%  
From Investments Rs m952109 872.3%  
From Financial Activity Rs m-368-959 38.4%  
Net Cashflow Rs m-109-16 662.4%  

Share Holding

Indian Promoters % 0.0 73.7 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.4 184.1%  
FIIs % 0.0 0.4 6.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 26.3 111.5%  
Shareholders   45,141 7,616 592.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   DR HABEEBULLAH LIFE SCIENCES  BRAWN BIOTECH  UNITECH INTERN.  HARIA EXPORT  BINDAL EXPORTS  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Nov 26, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - MISHKA EXIM COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS